Literature DB >> 19056123

Measuring relative efficiency of government-sponsored R&D projects: a three-stage approach.

Fang-Ming Hsu1, Chao-Chih Hsueh.   

Abstract

Without considering differences in operating environment, traditional methods of efficiency evaluation are suffering from external environmental influences. This study presents an alternative approach for assessing the relative efficiency of government-sponsored research and development projects (GSP). A three-stage approach employing data envelopment analysis to evaluate efficiency and Tobit regression to control external variables was applied to 110 projects over 9 years. This study finds that firm size, industry, and ratio of public subsidy on research and development (R&D) budget of recipient firm significantly influences the technical efficiency of GSP in Taiwan. After controlling these external variables, the mean value of technical efficiency in the third stage increases and becomes significantly different to that in the first stage. Most GSPs increase their returns when their projects are scaled up. Furthermore, government policy makers must establish the upper-limit ratio of subsidies on R&D budgets of recipient firms to avoid inefficient use of public funds.

Mesh:

Year:  2008        PMID: 19056123     DOI: 10.1016/j.evalprogplan.2008.10.005

Source DB:  PubMed          Journal:  Eval Program Plann        ISSN: 0149-7189


  3 in total

1.  Analyzing the efficiency of small and medium-sized enterprises of a national technology innovation research and development program.

Authors:  Sungmin Park
Journal:  Springerplus       Date:  2014-08-04

2.  Differences in technology innovation R&D performance creation behavior between for-profit institutions and not-for-profit institutions.

Authors:  Sungmin Park
Journal:  Springerplus       Date:  2016-04-14

3.  Implementation Efficiency of Corporate Social Responsibility in the Construction Industry: A China Study.

Authors:  Xuetong Wang; Wenyong Lai; Xiangnan Song; Chen Lu
Journal:  Int J Environ Res Public Health       Date:  2018-09-14       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.